Recent case study highlights the importance of applying statistical rigor throughout the development and validation processes of biomarkers.
Elisabeth Coart, PhD
Advertisement
Articles by Elisabeth Coart, PhD
Applied Clinical Trials
The development and qualification of biomarkers are keys to the future of drug development and precision medicine, particularly in oncology.
Advertisement
Latest Updated Articles
- Integration of Biomarker Validation in Oncology Trials
August 13th 2020
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When There’s No Registry: Building Rare Disease Evidence That Supports Regulatory Scrutiny
2
How to recruit specialty volunteer populations for early-phase clinical research: 5 things to ask when choosing a CRO partner
3
Sponsor Oversight in an Outsourced Trial: What Good Looks Like and How to Evidence It
4
How AI Is Changing Endpoint Selection Before a Trial Even Starts
5